Holdings (Monthly)
Guide ↗
Fidelity Advisor Health Care Fund
· Fidelity Advisor Series VII| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | BOSTON SCIENTIFIC CORP | 101137107 | Apr 2024 | 2,480,000 | $232.0M | 7.14% | EC |
| 2 | ELI LILLY and CO | 532457108 | Apr 2024 | 202,000 | $209.5M | 6.45% | EC |
| 3 | DANAHER CORP | 235851102 | Apr 2024 | 928,000 | $203.1M | 6.25% | EC |
| 4 | JOHNSON and JOHNSON | 478160104 | Jan 2026 | 515,000 | $117.0M | 3.60% | EC |
| 5 | Fidelity Revere Street Trust | 31635A303 | Apr 2024 | 101,406,154 | $101.4M | 3.12% | STIV |
| 6 | ABBVIE INC | 00287Y109 | Jan 2026 | 440,000 | $98.1M | 3.02% | EC |
| 7 | ARGENX SE | 04016X101 | Apr 2024 | 109,000 | $91.6M | 2.82% | EC |
| 8 | UCB SA | N/A | Apr 2024 | 280,000 | $84.8M | 2.61% | EC |
| 9 | ASCENDIS PHARMA A/S | 04351P101 | Apr 2024 | 370,000 | $83.7M | 2.57% | EC |
| 10 | CVS HEALTH CORP | 126650100 | Apr 2024 | 950,000 | $70.8M | 2.18% | EC |
| 11 | MASIMO CORP | 574795100 | Apr 2024 | 500,000 | $68.7M | 2.11% | EC |
| 12 | EDWARDS LIFESCIENCES CORP | 28176E108 | Apr 2024 | 828,000 | $67.4M | 2.07% | EC |
| 13 | VEEVA SYS INC | 922475108 | Apr 2024 | 308,000 | $62.8M | 1.93% | EC |
| 14 | THERMO FISHER SCIENTIFIC INC | 883556102 | Apr 2024 | 108,000 | $62.5M | 1.92% | EC |
| 15 | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | Apr 2024 | 167,000 | $56.5M | 1.74% | EC |
| 16 | GILEAD SCIENCES INC | 375558103 | Jan 2026 | 390,000 | $55.4M | 1.70% | EC |
| 17 | UNITEDHEALTH GROUP INC | 91324P102 | Apr 2024 | 180,000 | $51.6M | 1.59% | EC |
| 18 | MERCK and CO INC | 58933Y105 | Apr 2024 | 460,000 | $50.7M | 1.56% | EC |
| 19 | VIRIDIAN THERAPEUTICS INC | 92790C104 | Apr 2024 | 1,500,000 | $49.5M | 1.52% | EC |
| 20 | COGENT BIOSCIENCES INC | 19240Q201 | Jan 2026 | 1,360,000 | $48.8M | 1.50% | EC |
| 21 | PENUMBRA INC | 70975L107 | Apr 2024 | 130,000 | $46.6M | 1.43% | EC |
| 22 | MODERNA INC | 60770K107 | Jan 2026 | 1,020,000 | $45.0M | 1.38% | EC |
| 23 | INSULET CORP | 45784P101 | Apr 2024 | 174,000 | $44.5M | 1.37% | EC |
| 24 | IQVIA HOLDINGS INC | 46266C105 | Apr 2024 | 186,000 | $42.8M | 1.32% | EC |
| 25 | BRIGHTSPRING HEALTH SERVICES INC | 10950A106 | Apr 2024 | 1,080,000 | $42.4M | 1.30% | EC |
| 26 | NUVALENT INC | 670703107 | Apr 2024 | 400,000 | $41.2M | 1.27% | EC |
| 27 | INSMED INC | 457669307 | Apr 2024 | 250,000 | $39.2M | 1.21% | EC |
| 28 | LEGEND BIOTECH CORP | 52490G102 | Apr 2024 | 2,052,384 | $35.9M | 1.11% | EC |
| 29 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Jan 2026 | 690,000 | $34.5M | 1.06% | EC |
| 30 | ROCHE HOLDING AG | N/A | Apr 2024 | 75,000 | $34.1M | 1.05% | EC |
| 31 | WAYSTAR HOLDING CORP | 946784105 | Jan 2026 | 1,280,000 | $34.0M | 1.05% | EC |
| 32 | MCKESSON CORP | 58155Q103 | Jan 2026 | 40,000 | $33.2M | 1.02% | EC |
| 33 | CARIS LIFE SCIENCES INC | 142152107 | Jan 2026 | 1,420,000 | $32.9M | 1.01% | EC |
| 34 | ROYALTY PHARMA PLC | N/A | Apr 2024 | 760,000 | $31.7M | 0.97% | EC |
| 35 | STRUCTURE THERAPEUTICS INC | 86366E106 | Apr 2024 | 350,000 | $31.0M | 0.95% | EC |
| 36 | VAXCYTE INC | 92243G108 | Apr 2024 | 560,000 | $30.0M | 0.92% | EC |
| 37 | REPLIGEN CORP | 759916109 | Apr 2024 | 200,000 | $29.9M | 0.92% | EC |
| 38 | STRYKER CORP | 863667101 | Apr 2024 | 80,000 | $29.6M | 0.91% | EC |
| 39 | XENON PHARMACEUTICALS INC | 98420N105 | Apr 2024 | 690,000 | $28.3M | 0.87% | EC |
| 40 | DISC MEDICINE INC | 254604101 | Jan 2026 | 365,000 | $28.2M | 0.87% | EC |
| 41 | PRIVIA HEALTH GROUP INC | 74276R102 | Apr 2024 | 1,180,000 | $27.4M | 0.84% | EC |
| 42 | INTUITIVE SURGICAL INC | 46120E602 | Apr 2024 | 52,800 | $26.6M | 0.82% | EC |
| 43 | PRAXIS PRECISION MEDICINES INC. | 74006W207 | Jan 2026 | 82,000 | $25.7M | 0.79% | EC |
| 44 | ALIGNMENT HEALTHCARE INC | 01625V104 | Apr 2024 | 1,120,000 | $25.2M | 0.78% | EC |
| 45 | MEDLINE INC | 58507V107 | Jan 2026 | 560,000 | $24.8M | 0.76% | EC |
| 46 | BIONTECH SE | 09075V102 | Jan 2026 | 208,000 | $23.7M | 0.73% | EC |
| 47 | CG ONCOLOGY INC | 156944100 | Jan 2026 | 428,000 | $22.3M | 0.69% | EC |
| 48 | CENTESSA PHARMACEUTICALS PLC | 152309100 | Jan 2026 | 850,000 | $20.9M | 0.64% | EC |
| 49 | ORUKA THERAPEUTICS INC | 687604108 | Jan 2026 | 600,000 | $20.5M | 0.63% | EC |
| 50 | 10X GENOMICS INC | 88025U109 | Apr 2024 | 1,000,000 | $20.2M | 0.62% | EC |
| 51 | WAVE LIFE SCIENCES LTD | N/A | Apr 2024 | 1,550,000 | $20.1M | 0.62% | EC |
| 52 | VERACYTE INC | 92337F107 | Jan 2026 | 520,000 | $19.8M | 0.61% | EC |
| 53 | CYTOKINETICS INC | 23282W605 | Apr 2024 | 308,000 | $19.5M | 0.60% | EC |
| 54 | ENLIVEN THERAPEUTICS INC | 29337E102 | Apr 2024 | 670,000 | $17.7M | 0.55% | EC |
| 55 | OLEMA PHARMACEUTICALS INC | 68062P106 | Jan 2026 | 670,000 | $17.2M | 0.53% | EC |
| 56 | MINERALYS THERAPEUTICS INC | 603170101 | Jan 2026 | 540,000 | $16.7M | 0.51% | EC |
| 57 | CIGNA GROUP (THE) | 125523100 | Apr 2024 | 60,000 | $16.4M | 0.51% | EC |
| 58 | BEONE MEDICINES LTD | 07725L102 | Jan 2026 | 48,000 | $16.3M | 0.50% | EC |
| 59 | SPYRE THERAPEUTICS INC | 00773J202 | Apr 2024 | 470,351 | $15.0M | 0.46% | EC |
| 60 | LIFESTANCE HEALTH GROUP INC | 53228F101 | Apr 2024 | 2,080,000 | $14.7M | 0.45% | EC |
| 61 | PHARVARIS BV | N/A | Apr 2024 | 500,000 | $13.5M | 0.42% | EC |
| 62 | UPSTREAM BIO INC | 91678A107 | Jan 2026 | 400,000 | $12.4M | 0.38% | EC |
| 63 | STOKE THERAPEUTICS INC | 86150R107 | Jan 2026 | 385,000 | $11.7M | 0.36% | EC |
| 64 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Apr 2024 | 264,513 | $11.6M | 0.36% | EC |
| 65 | HEARTFLOW INC | HTFL | Apr 2024 | 371,723 | $11.1M | 0.34% | EC |
| 66 | KESTRA MEDICAL TECHNOLOGIES INC | N/A | Apr 2024 | 450,000 | $11.1M | 0.34% | EC |
| 67 | AXSOME THERAPEUTICS INC | 05464T104 | Jan 2026 | 60,000 | $11.1M | 0.34% | EC |
| 68 | CLEERLY INC | N/A | Apr 2024 | 882,089 | $11.0M | 0.34% | EP |
| 69 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Apr 2024 | 350,000 | $10.9M | 0.34% | EC |
| 70 | ROIVANT SCIENCES LTD | N/A | Apr 2024 | 500,000 | $10.8M | 0.33% | EC |
| 71 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Jan 2026 | 715,000 | $10.2M | 0.31% | EC |
| 72 | VIKING THERAPEUTICS INC | 92686J106 | Apr 2024 | 350,000 | $10.2M | 0.31% | EC |
| 73 | CYTOMX THERAPEUTICS INC | 23284F105 | Jan 2026 | 1,750,000 | $10.0M | 0.31% | EC |
| 74 | ZENAS BIOPHARMA INC | 98937L105 | Jan 2026 | 500,000 | $9.2M | 0.28% | EC |
| 75 | TRAVERE THERAPEUTICS INC | 89422G107 | Jan 2026 | 285,000 | $8.9M | 0.27% | EC |
| 76 | IMMUNOCORE HOLDINGS PLC | 45258D105 | Apr 2024 | 260,000 | $8.5M | 0.26% | EC |
| 77 | Fidelity Revere Street Trust | 31635A105 | Apr 2024 | 8,278,814 | $8.3M | 0.25% | STIV |
| 78 | SOLENO THERAPEUTICS INC | 834203309 | Jan 2026 | 210,000 | $8.1M | 0.25% | EC |
| 79 | UNIQURE N.V. | N/A | Apr 2024 | 350,000 | $8.0M | 0.24% | EC |
| 80 | GUARDANT HEALTH INC | 40131M109 | Jan 2026 | 69,000 | $7.9M | 0.24% | EC |
| 81 | SURGERY PARTNERS INC | 86881A100 | Apr 2024 | 500,000 | $7.4M | 0.23% | EC |
| 82 | SUMMIT THERAPEUTICS INC | 86627T108 | Apr 2024 | 500,000 | $7.2M | 0.22% | EC |
| 83 | BIOGEN INC | 09062X103 | Jan 2026 | 40,000 | $7.2M | 0.22% | EC |
| 84 | OMADA HEALTH INC | 68170A108 | Jan 2026 | 450,000 | $6.7M | 0.21% | EC |
| 85 | MEDICAL MICROINSTRUMENTS INC | N/A | Apr 2024 | 199,633 | $6.7M | 0.21% | EP |
| 86 | KARDIUM INC/US | N/A | Apr 2024 | 9,890,038 | $5.6M | 0.17% | EP |
| 87 | ENDEAVOR BIOMEDICINES INC | N/A | Apr 2024 | 863,746 | $5.6M | 0.17% | EP |
| 88 | INSIGHTEC LTD | N/A | Apr 2024 | 7,391,153 | $5.6M | 0.17% | EP |
| 89 | TREVI THERAPEUTICS INC | 89532M101 | Jan 2026 | 500,000 | $5.2M | 0.16% | EC |
| 90 | REVOLUTION MEDICINES INC | 76155X100 | Jan 2026 | 50,000 | $4.8M | 0.15% | EC |
| 91 | ANNEXON INC | 03589W102 | Jan 2026 | 750,000 | $4.7M | 0.14% | EC |
| 92 | RAPPORT THERAPEUTICS INC | 75383L102 | Jan 2026 | 168,000 | $4.5M | 0.14% | EC |
| 93 | JADE BIOSCIENCES INC | 008064206 | Jan 2026 | 280,000 | $4.4M | 0.13% | EC |
| 94 | KYMERA THERAPEUTICS INC | 501575104 | Jan 2026 | 56,700 | $4.1M | 0.13% | EC |
| 95 | ASTRANA HEALTH INC | 03763A207 | Jan 2026 | 180,380 | $4.1M | 0.13% | EC |
| 96 | OUTSET MEDICAL INC | 690145206 | Jan 2026 | 800,000 | $4.0M | 0.12% | EC |
| 97 | ALEDADE INC | N/A | Apr 2024 | 130,618 | $4.0M | 0.12% | EP |
| 98 | CONTINEUM THERAPEUTICS INC | 21217B100 | Jan 2026 | 280,000 | $4.0M | 0.12% | EC |
| 99 | SHOULDER INNOVATIONS INC | N/A | Apr 2024 | 256,192 | $3.6M | 0.11% | EC |
| 100 | APOGEE THERAPEUTICS INC | 03770N101 | Apr 2024 | 49,416 | $3.2M | 0.10% | EC |
| 101 | SCHOLAR ROCK HOLDING CORP | 80706P103 | Jan 2026 | 71,835 | $3.2M | 0.10% | EC |
| 102 | KARDIUM INC/US | N/A | Apr 2024 | 2,488,028 | $2.9M | 0.09% | DBT |
| 103 | ELEMENT BIOSCIENCES INC | N/A | Apr 2024 | 376,690 | $2.8M | 0.09% | EP |
| 104 | PARABILIS MEDICINES INC | N/A | Apr 2024 | 456,500 | $2.8M | 0.09% | EP |
| 105 | GALECTO INC | N/A | Apr 2024 | 100 | $2.6M | 0.08% | EP |
| 106 | FAHEAL TUB HOLDINGS LLC | N/A | Apr 2024 | 6,800 | $2.4M | 0.08% | EC |
| 107 | CANDID THERAPEUTICS | N/A | Apr 2024 | 1,956,465 | $2.4M | 0.07% | EP |
| 108 | MANUS BIO INC | N/A | Apr 2024 | 695,694 | $2.3M | 0.07% | EP |
| 109 | ZENAS BIOPHARMA INC | N/A | Apr 2024 | 122,099 | $2.2M | 0.07% | EC |
| 110 | OCULAR THERAPEUTIX INC | 67576A100 | Jan 2026 | 224,148 | $2.0M | 0.06% | EC |
| 111 | ASIMOV INC | N/A | Apr 2024 | 67,547 | $1.9M | 0.06% | EP |
| 112 | SALUDA MEDICAL INC | N/A | Apr 2024 | 215,913 | $1.9M | 0.06% | EC |
| 113 | GALVANIZE THERAPEUTICS | N/A | Apr 2024 | 2,552,870 | $1.8M | 0.06% | EP |
| 114 | ACUMEN PHARMACEUTICALS INC | 00509G209 | Apr 2024 | 700,000 | $1.8M | 0.06% | EC |
| 115 | PERCEPTIVE CAPITAL SOLUTIONS CORP | N/A | Apr 2024 | 169,200 | $1.7M | 0.05% | EC |
| 116 | GALVANIZE THERAPEUTICS | N/A | Apr 2024 | 3,668,545 | $1.7M | 0.05% | EP |
| 117 | DMED BIOPHARMACEUTICAL CO LTD | N/A | Apr 2024 | 205,024 | $1.6M | 0.05% | EP |
| 118 | WUGEN INC | N/A | Apr 2024 | 1,433,586 | $1.5M | 0.05% | DBT |
| 119 | PROCEPT BIOROBOTICS CORP | 74276L105 | Apr 2024 | 50,000 | $1.4M | 0.04% | EC |
| 120 | GALVANIZE THERAPEUTICS | N/A | Apr 2024 | 1,101,674 | $1.4M | 0.04% | DBT |
| 121 | ALEDADE INC | N/A | Apr 2024 | 46,526 | $1.4M | 0.04% | EP |
| 122 | GALECTO INC | 36322Q206 | Jan 2026 | 50,000 | $1.3M | 0.04% | EC |
| 123 | KARDIUM INC/US | N/A | Apr 2024 | 2,164,613 | $1.2M | 0.04% | EP |
| 124 | ELEMENT BIOSCIENCES INC | N/A | Apr 2024 | 246,623 | $1.1M | 0.04% | EP |
| 125 | ELEMENT BIOSCIENCES INC | N/A | Apr 2024 | 246,623 | $1.1M | 0.04% | EP |
| 126 | FAHEAL THRIVE HOLDINGS LLC | N/A | Apr 2024 | 327,591 | $835K | 0.03% | EC |
| 127 | SALUDA MEDICAL INC | N/A | Apr 2024 | 966,580 | $831K | 0.03% | EC |
| 128 | SHOULDER INNOVATIONS INC | 82537J108 | Jan 2026 | 54,500 | $772K | 0.02% | EC |
| 129 | ORUKA THERAPEUTICS INC | N/A | Apr 2024 | 21,901 | $750K | 0.02% | EC |
| 130 | IMMUNOME INC | 45257U108 | Jan 2026 | 24,571 | $605K | 0.02% | EC |
| 131 | WUGEN INC | N/A | Apr 2024 | 300,054 | $477K | 0.01% | EP |
| 132 | ELEVATEBIO, LLC | N/A | Apr 2024 | 163,300 | $331K | 0.01% | EP |
| 133 | KARDIUM INC/US | N/A | Apr 2024 | 450,354 | $257K | 0.01% | EP |
| 134 | MEDICAL MICROINSTRUMENTS INC | N/A | Apr 2024 | 9,982 | $127K | 0.00% | EC |